ESC 365 - Endotrophin, quantified by a novel assay, is prognostic of all-cause mortality in two different cohorts of patients with heart failure with preserved ejection fraction

HFA Premium Access

Endotrophin, quantified by a novel assay, is prognostic of all-cause mortality in two different cohorts of patients with heart failure with preserved ejection fraction

Session: Pathophysiology, detection and biomarkers

Topic: Biomarkers

Speaker: Ms E. Angeli (Herlev, DK)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Ms Elisavet Angeli

Nordic Bioscience, Herlev (Denmark)

1 presentation

0 follower

6 more presentations in this session

Linking brain innate immunity, energy metabolism, and HFpEF: hypothalamic complement C3/C3a/C3aR pathway drives cardiometabolic syndrome and HFpEF via central SOCS3 activation

Speaker: Doctor E. Rawish (Luebeck, DE)

Investigating the role of the long non-coding RNA lncFOX in cardiovascular disease

Speaker: Ms L. Oehlsen (Hannover, DE)

Inflammation in acute myocarditis: single-cell RNA sequencing identifies key immune cell signatures and disease progression markers

Speaker: Doctor C. Panico (Rozzano, IT)

Titin mediates control of cardiomyocyte proliferation

Speaker: Doctor A. Paldino (Trieste, IT)

Development of a remote assessment technique to measure the interstitial fluid pressure for fluid status monitoring in heart failure

Speaker: Doctor H. Zafar (Sheffield, GB)

Access the full session

Pathophysiology, detection and biomarkers

Speakers: Ms E. Angeli, Doctor E. Rawish, Ms L. Oehlsen, Doctor C. Panico, Doctor A. Paldino...

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources